Company intelligence / Profile preview

Asia Genomics

Singapore, Central Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

Asia Genomics provides safe, accurate and timely genetic testing services. The company experienced a 23.6% drop in revenue for the financial year ended September 30, 2022, but maintained a positive bottom line.

Therapeutic areas: OtherOncologyWomen's Health
Modalities: Genetic testingdiagnostic tests
Industry: Molecular Diagnostics

Partnerships

NantHealth (GPS Cancer partnership for Southeast Asia expansion)

Beyond the preview

Go deeper on Asia Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asia Genomics.

Explore the full profile